VYNE Pharmaceuticals Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.0M
Doctors Paid
5,975
Transactions
26,793
2022 Total
$32,525
Payment Breakdown by Category
Research$3.1M (61.7%)
Food & Beverage$556,294 (11.0%)
Travel$86,730 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.1M | 921 | 61.7% |
| Honoraria | $1.3M | 617 | 25.6% |
| Food and Beverage | $556,294 | 25,000 | 11.0% |
| Travel and Lodging | $86,730 | 255 | 1.7% |
Payments by Type
Research
$3.1M
921 transactions
General
$1.9M
25,872 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| FX2016-40 | $1.5M | 0 | 263 |
| MTI-105 | $588,070 | 0 | 327 |
| MTI-107 | $544,768 | 0 | 277 |
| MTI-117 | $370,845 | 0 | 40 |
| A Prospective, Multicenter, Randomized, Evaluator-Blinded, Study to Evaluate the Safety and Efficacy of AMZEEQ Companion Treatment with Oral Isotretinoin Therapy in Patients with Moderate to Severe Acne Vulgaris | $112,820 | 0 | 14 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Dr. Christopher Remishofsky, Md, MD | Dermatology | Sterling Heights, MI | $6,770 | $0 |
| Harry Greenberg, Md, MD | Dermatology | Las Vegas, NV | $6,593 | $0 |
| Dr. Michael Gold, M.d, M.D | Specialist | Nashville, TN | $6,341 | $0 |
| Mr. Tomas Chao, Pa, PA | Medical | Woodstock, GA | $6,187 | $0 |
| Mrs. Gina Fragione, Pa, PA | Physician Assistant | Graham, WA | $5,438 | $0 |
| Dr. Tory Sullivan, M.d, M.D | Obesity Medicine | North Miami Beach, FL | $5,391 | $0 |
| Dr. Sarah Jackson, M.d, M.D | Dermatology | New Orleans, LA | $4,952 | $0 |
| Dr. Rania Agha, M.d, M.D | Dermatology | Oakbrook Terrace, IL | $4,903 | $0 |
| Andrew Alexis, Md, MD | Dermatology | New York, NY | $4,500 | $0 |
| Mr. Joe Gorelick, N.p, N.P | Nurse Practitioner | San Jose, CA | $4,246 | $0 |
| Mr. Gilberto Saenz, Physician Assistant, PHYSICIAN ASSISTANT | Surgical | Georgetown, TX | $3,960 | $0 |
| Mrs. Jaime Dunn, Pa, PA | Medical | Birmingham, AL | $3,729 | $0 |
| Dr. Valerie Callender, M.d, M.D | Dermatology | Glenn Dale, MD | $3,541 | $0 |
| Dr. Michelle Dawson, M.d, M.D | Student in an Organized Health Care Education/Training Program | Clarkston, MI | $3,410 | $0 |
| Stacy Blum, D.o, D.O | Dermatology | Wentzville, MO | $3,390 | $0 |
| Dr. Harold Farber, M.d,, M.D, | Dermatology | Philadelphia, PA | $3,241 | $0 |
| Lawrence Eichenfield, M.d, M.D | Pediatric Dermatology | San Diego, CA | $2,521 | $0 |
| Dr. Matthew Zirwas, Md, MD | Dermatology | Bexley, OH | $2,506 | $0 |
| Theodore Rosen, Md, MD | Dermatology | Houston, TX | $2,506 | $0 |
| Thushan Desilva, M.d, M.D | Dermatology | Boerne, TX | $2,260 | $0 |
| Nanette Silverberg, Md, MD | Pediatric Dermatology | New York, NY | $2,164 | $0 |
| Andrea Nguyen, Pa-C, PA-C | Physician Assistant | Irvine, CA | $2,138 | $0 |
| Ms. Leslie Mazur, Pa, PA | Medical | Littleton, CO | $2,108 | $0 |
| Steven Kempers, M.d, M.D | Specialist | Fridley, MN | $2,100 | $0 |
| James Jackson, Md, MD | Dermatology | Louisville, KY | $2,100 | $0 |
Ad
Top Products
- Serlopitant $1.5M
- FCD105 $1.5M
Associated Products (4)
- Serlopitant $1.5M
- FCD105 $1.5M
- AMZEEQ $1.3M
- ZILXI $767,479
Payment Categories
- Food & Beverage $556,294
- Travel & Lodging $86,730
- Research $3.1M
About VYNE Pharmaceuticals Inc.
VYNE Pharmaceuticals Inc. has made $5.0M in payments to 5,975 healthcare providers, recorded across 26,793 transactions in the CMS Open Payments database. In 2022, the company paid $32,525. The top product by payment volume is Serlopitant ($1.5M).
Payments were distributed across 88 medical specialties. The top specialty by payment amount is Dermatology ($1.4M to 2,709 doctors).
Payment categories include: Food & Beverage ($556,294), Research ($3.1M), Travel & Lodging ($86,730).
VYNE Pharmaceuticals Inc. is associated with 4 products in the CMS Open Payments database, including Serlopitant, FCD105, and AMZEEQ.